91 related articles for article (PubMed ID: 9606809)
1. Dysregulation of apoptosis in hepatocellular carcinoma.
Thorgeirsson SS; Teramoto T; Factor VM
Semin Liver Dis; 1998; 18(2):115-22. PubMed ID: 9606809
[TBL] [Abstract][Full Text] [Related]
2. Biology of transforming growth factor beta in hepatocarcinogenesis.
Rossmanith W; Schulte-Hermann R
Microsc Res Tech; 2001 Feb; 52(4):430-6. PubMed ID: 11170302
[TBL] [Abstract][Full Text] [Related]
3. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis.
Tanaka S; Wands JR
Cancer Res; 1996 Aug; 56(15):3391-4. PubMed ID: 8758899
[TBL] [Abstract][Full Text] [Related]
4. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
[TBL] [Abstract][Full Text] [Related]
5. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
6. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
[TBL] [Abstract][Full Text] [Related]
7. Prevention of TGF-beta-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways.
Lin SJ; Chang C; Ng AK; Wang SH; Li JJ; Hu CP
Apoptosis; 2007 Sep; 12(9):1659-70. PubMed ID: 17624592
[TBL] [Abstract][Full Text] [Related]
8. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S
Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
10. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of growth factor signaling in human hepatocellular carcinoma.
Breuhahn K; Longerich T; Schirmacher P
Oncogene; 2006 Jun; 25(27):3787-800. PubMed ID: 16799620
[TBL] [Abstract][Full Text] [Related]
12. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cells.
Herzer K; Ganten TM; Schulze-Bergkamen H; Grosse-Wilde A; Koschny R; Krammer PH; Walczak H
Hepatology; 2005 Jul; 42(1):183-92. PubMed ID: 15962328
[TBL] [Abstract][Full Text] [Related]
14. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.
Chen RH; Su YH; Chuang RL; Chang TY
Oncogene; 1998 Oct; 17(15):1959-68. PubMed ID: 9788439
[TBL] [Abstract][Full Text] [Related]
15. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
Park HJ; Kim BC; Kim SJ; Choi KS
Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
[TBL] [Abstract][Full Text] [Related]
16. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
Paik SY; Park YN; Kim H; Park C
Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity.
Carmona-Cuenca I; Roncero C; Sancho P; Caja L; Fausto N; Fernández M; Fabregat I
J Hepatol; 2008 Dec; 49(6):965-76. PubMed ID: 18845355
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.
Herzer K; Grosse-Wilde A; Krammer PH; Galle PR; Kanzler S
Mol Cancer Res; 2008 Jul; 6(7):1169-77. PubMed ID: 18644981
[TBL] [Abstract][Full Text] [Related]
19. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
Chen C; Chang YC; Liu CL; Liu TP; Chang KJ; Guo IC
Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064
[TBL] [Abstract][Full Text] [Related]
20. Expression of transforming growth factor-beta 1 in hepatocellular carcinoma in comparison with the non-tumor tissue.
Idobe Y; Murawaki Y; Kitamura Y; Kawasaki H
Hepatogastroenterology; 2003; 50(49):54-9. PubMed ID: 12629989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
